Rheumatology
Victoria Shanmugam, MD, director of the Division of Rheumatology and professor of medicine, spoke to Tegna Broadcasting for a segment on whether COVID-19 vaccines are as effective for immunocompromised people.
A recent study by GW physicians on the severity of acute respiratory viral adverse events related to antirheumatic disease therapies found that some therapies may be associated with increased respiratory viral events while others don’t show increased frequency.
Research led by Nadine Mbuyi, MD, found that gout patients spend longer time in the ED than the national median across all medical illnesses.
Chronic rheumatic diseases may make patients more susceptible to contracting COVID-19 and may effect the severity of the virus. Adam Kilian, MD, is serving as a regional leader for the COVID-19 Global Rheumatology Alliance, which is collecting and analyzing clinical data from…
Victoria Shanmugam, MD, chief of the Division of Rheumatology and associate professor of medicine, spoke with WUSA9 for an article on whether people can still take elderberry to boost their immune system during the COVID-19 pandemic or if it will create a cytokine storm.
A recent study determined that the Collaborative National Quality and Efficacy Registry for scleroderma, or systemic sclerosis, is a powerful tool in guiding research and treatment development for the disease.
First-year MD student Amil Agarwal presented a poster on hidradenitis suppurativa at the American College of Rheumatology's annual meeting in November.
In a new paper published in Seminars in Arthritis and Rheumatism, researchers from GW evaluated the long-term outcomes for patients with juvenile idiopathic inflammatory myopathies.
Faculty at the George Washington University School of Medicine and Health Sciences (SMHS) will take part in the American College of Rheumatology’s (ACR) 2019 Annual Meeting in November in Atlanta.
Victoria Shanmugam, MD, published study on hidradenitis suppurativa in the journal Clinical and Experimental Dermatology.